Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation

Resource type
Journal Article
Authors/contributors
Title
Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation
Abstract
BK virus-associated hemorrhagic cystitis (BKV-HC) is a common complication of allogenic hematopoietic stem cell transplantation (AHSCT), particularly in recipients of alternative donor transplants, which are being performed in increasing numbers. BKV-HC typically results in painful hematuria, urinary obstruction, and renal dysfunction, without a definitive therapeutic option.
Publication
Journal of Clinical Oncology
Date
2021-8-20
Volume
39
Issue
24
Pages
2710-2719
Journal Abbr
J Clin Oncol
Accessed
11/2/23, 9:39 AM
ISSN
0732-183X
Library Catalog
PubMed Central
Extra
PMID: 33929874 PMCID: PMC10166368
Citation
Olson, A., Lin, R., Marin, D., Rafei, H., Bdaiwi, M. H., Thall, P. F., Basar, R., Abudayyeh, A., Banerjee, P., Aung, F. M., Kaur, I., Abueg, G., Rao, S., Chemaly, R., Mulanovich, V., Al-Atrash, G., Alousi, A. M., Andersson, B. S., Anderlini, P., … Rezvani, K. (2021). Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation. Journal of Clinical Oncology, 39(24), 2710–2719. https://doi.org/10.1200/JCO.20.02608
DRUGS AND THERAPIES